References
- SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
- ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
- VenookAPPapandreouCFuruseJde GuevaraLLThe incidence and epidemiology of hepatocellular carcinoma: a global and regional perspectiveOncologist201015suppl 4513
- WhiteDLThriftAPKanwalFDavilaJEl-SeragHBIncidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012Gastroenterology Epub20161123
- BaloghJVictorD3rdAshamEHHepatocellular carcinoma: a reviewJ Hepatocell Carcinoma20163415327785449
- ColagrandeSInghilesiALAburasSTalianiGGNardiCMarraFChallenges of advanced hepatocellular carcinomaWorld J Gastroenterol201622347645765927678348
- JanssensSBeyaertRFunctional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family membersMol Cell200311229330212620219
- LiNJiangJFuJTargeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinomaJ Exp Clin Cancer Res201635114027619757
- CaoZHenzelWJGaoXIRAK: a kinase associated with the interleukin-1 receptorScience19962715252112811318599092
- FlannerySBowieAGThe interleukin-1 receptor-associated kinases: critical regulators of innate immune signallingBiochem Pharmacol201080121981199120599782
- WescheHHenzelWJShillinglawWLiSCaoZPillars article: MyD88: an adapter that recruits IRAK to the IL-1 receptor complexImmunity199778378479430229 J Immunol2013190151523264669
- GuhaMMackmanNLPS induction of gene expression in human monocytesCell Signal2001132859411257452
- ZhangGGhoshSToll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunityJ Clin Invest20011071131911134172
- RhyasenGWBolanosLFangJTargeting IRAK1 as a therapeutic approach for myelodysplastic syndromeCancer Cell20132419010423845443
- SrivastavaRGengDLiuYAugmentation of therapeutic responses in melanoma by inhibition of IRAK-1,-4Cancer Res201272236209621623041547
- BehrensCFengLKadaraHExpression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesionsClin Cancer Res2010161344420028769
- ZhangXDangYLiPRongMChenGExpression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray studyInt J Clin Exp Pathol20147118096810425550857
- ScheerenFAKuoAHvan WeeleLJA cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesisNat Cell Biol201416121238124825362351
- WeeZNYatimSMKohlbauerVKIRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxelNat Commun20156874626503059
- LiJJLuoJLuJNRelationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro studyCancer Cell Int2016167627708550
- LiJLiangLLiuYClinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosisOnco Targets Ther201691721173427051307
- GaoJAksoyBADogrusozUIntegrative analysis of complex cancer genomics and clinical profiles using the cBioPortalSci Signal20136269 pl1
- CeramiEGaoJDogrusozUThe cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics dataCancer Discov20122540140422588877
- LiZYoungerKGartenhausRInhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapiesJ Clin Invest201512531081109725642772
- O’NeillLAGolenbockDBowieAGThe history of toll-like receptors – redefining innate immunityNat Rev Immunol201313645346023681101
- Rakoff-NahoumSMedzhitovRToll-like receptors and cancerNat Rev Cancer200991576319052556
- FonteEAgathangelidisAReverberiDToll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferationHaematologica2015100111460146826294727
- KogoRMimoriKTanakaFKomuneSMoriMClinical significance of miR-146a in gastric cancer casesClin Cancer Res201117134277428421632853
- LiYVandenboomTG2ndWangZmiR-146a suppresses invasion of pancreatic cancer cellsCancer Res20107041486149520124483
- BhaumikDScottGKSchokrpurSPatilCKCampisiJBenzCCExpression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cellsOncogene200827425643564718504431
- YangDChenWXiongJSherrodCJHenryDHDittmerDPInterleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphomaProc Natl Acad Sci U S A201411144E4762E476825341731